News & Perspective

Oct 15, 2009

Oct 15, 2009

FDA faces decision about use of peramivir for H1N1

(CIDRAP News) – In response to questions from citizens at a meeting yesterday, a Food and Drug Administration (FDA) official said the agency would make a decision "fairly soon" about permitting emergency use of the experimental antiviral drug peramivir to help patients severely ill with pandemic H1N1 influenza.